Jemal A , Thomas A , Murray T , Thun M . Cancer Statistics 2002. CA Cancer J Clin. 2002;52:23–47. [PubMed: 11814064]

Sporn MB , Dunlop NM , Newton DL , Smith JM . Prevention of chemical carcinogenesis by vitamin A and its synthetic analogues (retinoids). Fed Proc. 1976;35:1332–8. [PubMed: 770206]

Sporn MB . Carcinogenesis and cancer: different perspectives on the same disease. Cancer Res. 1991;51:6215–8. [PubMed: 1933881]

Wattenberg LW . Chemoprevention of cancer. Cancer Res. 1985;45:1–8. [PubMed: 3880665]

Symposium on early lesions and the development of epithelial cancer. Cancer Res 1976; 36:2475–706.

Boone CW , Kelloff GJ , Steele VE . Natural history of intraepithelial neoplasia in humans with implications for cancer chemoprevention strategy. Cancer Res. 1992;52:1651–9. [PubMed: 1551096]

Sporn MB , Suh N . Chemoprevention: an essential approach to controlling cancer. Nat Rev Cancer. 2002;2:537–43. [PubMed: 12094240]

Kelloff GJ . Perspectives on cancer chemoprevention research and drug development. Adv Cancer Res. 1999;78:199–334. [PubMed: 10547671]

Fugh-Berman A , Epstein S . Tamoxifen: disease prevention or disease substitution? Lancet. 1992;340:1143–5. [PubMed: 1359220]

Ross R . The pathogenesis of atherosclerosis: a perspective for the 1990s. Nature. 1993;362:801–9. [PubMed: 8479518]

Manson JE , Tosteson H , Ridker PM . et al. The primary prevention of myocardial infarction. N Engl J Med. 1992;326:1406–16. [PubMed: 1533273]

Ames BN , Shigenaga MK , Hagen TM . Oxidants, antioxidants, and the degenerative diseases of aging. Proc Natl Acad Sci U S A. 1993;90:7915–22. [PMC free article: PMC47258] [PubMed: 8367443]

Sporn MB, Roberts AB, Goodman DS, editors. The retinoids. 2nd ed. New York: Raven Press; 1994.

Dawson MI, Hobbs PD. The synthetic chemistry of retinoids. In: Sporn MB, Roberts AB, Goodman DS, editors. The retinoids. 2nd ed. New York: Raven Press; 1994. p. 5–178.

Green S , Chambon P . A superfamily of potentially oncogenic hormone receptors. Nature. 1986;324:615–7. [PubMed: 3025739]

Evans RM . The steroid and thyroid hormone receptor super-family. Science. 1988;240:889–95. [PMC free article: PMC6159881] [PubMed: 3283939]

O'Malley B . The steroid receptor superfamily: more excitement predicted for the future. Mol Endocrinol. 1990;4:363–9. [PubMed: 2188115]

Wolbach SB , Howe PR . Tissue changes following deprivation of fat soluble A vitamin. J Exp Med. 1925;42:753–77. [PMC free article: PMC2131078] [PubMed: 19869087]

Sporn MB , Roberts AB . Role of retinoids in differentiation and carcinogenesis. Cancer Res. 1983;43:3034–40. [PubMed: 6189589]

Lasnitzki I . The influence of A hypervitaminosis on the effect of 20-methylcholanthrene on mouse prostate glands grown in vitro. Br J Cancer. 1955;9:434–41. [PMC free article: PMC2073703] [PubMed: 13269641]

Merriman RL , Bertram JS . Reversible inhibition by retinoids of 3-methylcholanthrene-induced neoplastic transformation in C3H/10T1/2 CL8 cells. Cancer Res. 1979;39:1661–6. [PubMed: 427803]

Strickland S , Mahdavi V . The induction of differentiation in teratocarcinoma stem cells by retinoic acid. Cell. 1978;15:393–403. [PubMed: 214238]

Breitman TR , Selonick SE , Collins SJ . Induction of differentiation of the human promyelocytic leukemia cell line (HL-60) by retinoic acid. Proc Natl Acad Sci U S A. 1980;77:2936–40. [PMC free article: PMC349521] [PubMed: 6930676]

Gudas LJ, Sporn MB, Roberts AB. Cellular biology and biochemistry of the retinoids. In: Sporn MB, Roberts AB, Goodman DS, editors. The retinoids. 2nd ed. New York: Raven Press; 1994. p. 443–520.

Allegretto EA , McClurg MR , Lazarchik SB . et al. Transactivation properties of retinoic acid and retinoid X receptors in mammalian cells and yeast. J Biol Chem. 1993;268:26625–33. [PubMed: 8253793]

Allenby G , Janoch R , Kazmer S . et al. Binding of 9-cis-retinoic acid and all-trans-retinoic acid to retinoic acid receptors α, β, and γ J Biol Chem. 1994;269:16689–95. [PubMed: 8206989]

Mangelsdorf DJ, Umesono K, Evans RM. The retinoid receptors. In: Sporn MB, Roberts AB, Goodman DS, editors. The retinoids. 2nd ed. New York: Raven Press; 1994. p. 319–49.

Moon RC, Mehta RG, Rao KV. Retinoids and cancer in experimental animals. In: Sporn MB, Roberts AB, Goodman DS, editors. The retinoids. 2nd ed. New York: Raven Press; 1994. p. 573–96.

Anzano MA , Byers SW , Smith JM . et al. Prevention of breast cancer in the rat with 9-cis-retinoic acid as a single agent and in combination with tamoxifen. Cancer Res. 1994;54:4614–7. [PubMed: 8062253]

Jordan VC, editor. Long-term tamoxifen treatment for breast cancer. Madison (WI): University of Wisconsin Press; 1994. p. 289.

Jordan VC , Allen KE , Dix CJ . Pharmacology of tamoxifen in laboratory animals. Cancer Treat Rep. 1980;64:745–9. [PubMed: 6775807]

Gottardis MM , Jordan VC . Antitumor actions of keoxifene and tamoxifen in the N-nitrosomethylurea-induced rat mammary carcinoma model. Cancer Res. 1987;47:4020–4. [PubMed: 3607747]

Knabbe C , Lippman ME , Wakefield LM . et al. Evidence that TGF-β is a hormonally regulated negative growth factor in human breast cancer cells. Cell. 1987;48:417–28. [PubMed: 2879636]

Colletta AA , Wakefield LM , Howell LM . et al. Antioestrogens induce the secretion of active TGF-β from human fetal fibroblasts. Br J Cancer. 1990;62:405–9. [PMC free article: PMC1971440] [PubMed: 1698443]

Butta A , MacLennan K , Flanders KC . et al. Induction of transforming growth factor β1 in human breast cancer in vivo following tamoxifen treatment. Cancer Res. 1992;52:4261–4. [PubMed: 1322240]

Nolvadex Adjuvant Trial Organization. . Controlled trial of tamoxifen as a single adjuvant agent in the management of early breast cancer. Br J Cancer. 1988;57:608–11. [PMC free article: PMC2246455] [PubMed: 2900647]

Colletti RB , Roberts JD , Devlin JT , Copeland KC . Effect of tamoxifen on plasma insulin-like growth factor I in patients with breast cancer. Cancer Res. 1989;49:1882–4. [PubMed: 2924327]

Pollak MJ , Costantino C , Polychronakos SA . et al. Effect of tamoxifen on serum insulin-like growth factor I levels in stage I breast cancer patients. J Natl Cancer Inst. 1990;82:1693–7. [PubMed: 2231756]

Black LJ , Sato M , Rowley ER . et al. Raloxifene (LY139481 HCI) prevents bone loss and reduces serum cholesterol without causing uterine hypertrophy in ovariectomized rats. J Clin Invest. 1994;93:63–9. [PMC free article: PMC293730] [PubMed: 8282823]

Lowe KE , Maiyar AC , Norman AW . Vitamin D-mediated gene expression. Crit Rev Eukaryot Gene Expr. 1992;2:65–109. [PubMed: 1543898]

Studzinski GP , McLane JA , Uskokovic MR . Signalling pathways for vitamin D-induced differentiation: implications for therapy of proliferative and neoplastic diseases. Crit Rev Eukaryot Gene Expr. 1993;3:279–312. [PubMed: 8286848]

Ikekawa N, Ishizuka S. Molecular structure and biological activity of vitamin D metabolites and their analogues. In: Bol M, Daux WL, editors. Molecular structure and biological activity of steroids. Boca Raton (FL): CRC Press; 1992. p. 293–316.

Anzano MA , Smith JM , Uskokovic MR . et al. 1α, 25-dihydroxy-16-ene-23-yne-26,27-hexafluorocholecalciferol (Ro24-5531), a new deltanoid (vitamin D analogue) for prevention of breast cancer in the rat. Cancer Res. 1994;54:1653–6. [PubMed: 8137276]

Guyton KZ , Kensler TW , Posner GH . Cancer chemoprevention using natural vitamin D and synthetic analogs. Annu Rev Pharmacol Toxicol. 2001;41:421–42. [PubMed: 11264464]

Stoner E . The clinical effects of a 5α-reductase inhibitor, finasteride, on benign prostatic hyperplasia. The Finasteride Study Group. J Urol. 1992;147:1298–302. [PubMed: 1373779]

Pegg AE . Polyamine metabolism and its importance in neoplastic growth and as a target for chemotherapy. Cancer Res. 1988;48:759–74. [PubMed: 3123052]

Ratko TA , Detrisac CJ , Rao KV . et al. Interspecies analysis of the chemopreventive efficacy of dietary α-difluoromethylornithine. Anticancer Res. 1990;10:67–72. [PubMed: 2110434]

Gupta RA , DuBois RN . Colorectal cancer prevention and treatment by inhibition of cyclooxygenase-2. Nature Rev Cancer. 2001;1:11–21. [PubMed: 11900248]

Prestera T , Zhang Y , Spencer SR . et al. The electrophile counterattack response: protection against neoplasia and toxicity. Adv Enzyme Regul. 1993;33:281–96. [PubMed: 8356913]

DeFlora S, Izzotti A, D'Agostini F, et al. Chemopreventive properties of N-acetylcysteine and other thiols. In: Wattenberg L, Lipkin M, Boone CW, Kelloff GJ, editors. Cancer chemoprevention. Boca Raton (FL): CRC Press; 1992. p. 183–94.

Kensler TW , Egner PA , Trush MA . et al. Mechanisms of protection against aflatoxin tumorigenicity in rats fed 5-(2-pyrazinyl)-4-methyl-1,2-dithiol-3-thione (oltipraz) and related 1,2-dithiol-3-thiones and 1,2-dithiol-3-ones. Cancer Res. 1987;47:4271–7. [PubMed: 2886217]

Lippman SM , Benner SE , Hong WK . Cancer chemoprevention. J Clin Oncol. 1994;12:851–73. [PubMed: 8151328]

Lippman SM , Lee JJ , Sabichi AL . Cancer chemoprevention: progress and promise. J Natl Cancer Inst. 1998;90:1514–28. [PubMed: 9790544]

Vokes EE , Weichselbaum RR , Lippman SM . et al. Head and neck cancer. N Engl J Med. 1993;328:184–94. [PubMed: 8417385]

Hong WK , Lippman SM , Hittelman WN . et al. Retinoid chemoprevention of aerodigestive cancer: from basic research to the clinic. Clin Cancer Res. 1995;1:677–86. [PubMed: 9816032]

Papadimitrakopoulou V , Izzo J , Lippman SM . et al. Frequent inactivation of p16 ^INK4a in oral premalignant lesions. Oncogene. 1997;14:1799–803. [PubMed: 9150385]

Lippman SM , Lee JS , Lotan R . et al. Biomarkers as intermediate end points in chemoprevention trials. J Natl Cancer Inst. 1990;82:555–60. [PubMed: 2179569]

Benner SE , Winn RJ , Lippman SM . et al. Regression of oral leukoplakia with α-tocopherol: a community clinical oncology program chemoprevention study. J Natl Cancer Inst. 1993;85:44–7. [PubMed: 8416256]

Hong WK , Endicott J , Itri LM . et al. 13-cis-retinoic acid in the treatment of oral leukoplakia. N Engl J Med. 1986;315:1501–5. [PubMed: 3537787]

Lippman SM , Batsakis JG , Toth BB . et al. Comparison of low-dose isotretinoin with β-carotene to prevent oral carcinogenesis. N Engl J Med. 1993;328:15–20. [PubMed: 8416267]

Papadimitrakopoulou VA , Hong WK , Lee JS . et al. Low-dose isotretinoin versus β-carotene to prevent oral carcinogenesis: long-term follow-up. J Natl Cancer Inst. 1997;89:257–8. [PubMed: 9017007]

Stich HF , Hornby AP , Mathew B . et al. Response of oral leukoplakias to the administration of vitamin A. Cancer Lett. 1988;40:93–101. [PubMed: 3370632]

Han J , Lu Y , Sun Z . et al. Evaluation of N-4-(hydroxycarbophenyl) retinamide as a cancer prevention agent and as a cancer chemotherapeutic agent. In Vivo. 1990;4:153–60. [PubMed: 2133256]

Chiesa F , Tradati N , Marazza M . et al. Fenretinide (4-HPR) in chemoprevention of oral leukoplakia. J Cell Biochem Suppl. 1993;17F:255–61. [PubMed: 8412202]

Epstein JB , Wong FLW , Millner A , Le ND . Topical bleomycin treatment of oral leukoplakia: a randomized double-blind clinical trial. Head Neck. 1994;16:539–44. [PubMed: 7529754]

Lotan R , Xu X-C , Lippman SM . et al. Suppression of retinoic acid receptor β in premalignant oral lesions and its upregulation by isotretinoin. N Engl J Med. 1995;332:1405–10. [PubMed: 7723796]

Lippman SM , Shin DM , Lee JJ . et al. p53 and retinoid chemoprevention of oral carcinogenesis. Cancer Res. 1995;55:16–9. [PubMed: 7805028]

Lippman SM , Hong WK . Molecular markers of the risk of oral cancer. N Engl J Med. 2001;344:1323–6. [PubMed: 11320393]

Hong WK , Lippman SM , Itri LM . et al. Prevention of second primary tumors with isotretinoin in squamous-cell carcinoma of the head and neck. N Engl J Med. 1990;323:795–801. [PubMed: 2202902]

Benner SE , Pajak TF , Lippman SM . et al. Prevention of second primary tumors with isotretinoin in squamous cell carcinoma of the head and neck: long term follow-up. J Natl Cancer Inst. 1994;86:140–1. [PubMed: 8271298]

Khuri FR , Kim ES , Lee JJ . et al. The impact of smoking status, disease stage, and index tumor site on second primary tumor incidence and tumor recurrence in the head and neck retinoid chemoprevention trial. Cancer Epidemiol Biomarkers Prev. 2001;10:823–9. [PubMed: 11489748]

Bolla M , Lefur R , Ton Van J . et al. Prevention of second primary tumours with etretinate in squamous cell carcinoma of the oral cavity and oropharynx: results of a multicentric double-blind randomized study. Eur J Cancer. 1994;30A:767–72. [PubMed: 7917535]

Mao L , Lee JS , Kurie JM . et al. Clonal genetic alterations in the lungs of current and former smokers. J Natl Cancer Inst. 1997;89:857–62. [PubMed: 9196251]

Arnold AM , Browman GP , Levine MN . et al. The effect of the synthetic retinoid etretinate on sputum cytology: results from a randomized trial. Br J Cancer. 1992;65:737–43. [PMC free article: PMC1977389] [PubMed: 1586601]

Lee JS , Lippman SM , Benner SE . et al. A randomized placebo-controlled trial of isotretinoin in chemoprevention of bronchial squamous metaplasia. J Clin Oncol. 1994;12:937–45. [PubMed: 8164045]

Kurie JM , Lee JS , Khuri FR . et al. N(4-hydroxyphenyl) retinamide in the chemoprevention of squamous metaplasia and dysplasia of the bronchial epithelium. Clin Cancer Res. 2000;6:2973–9. [PubMed: 10955773]

Heimburger DC , Alexander B , Birch R . et al. Improvement in bronchial squamous metaplasia in smokers treated with folate and vitamin B₁₂: report of a preliminary randomized, double-blind intervention trial. JAMA. 1988;259:1525–30. [PubMed: 3339790]

van Poppel G , Kok FJ , Hermus RJJ . Beta-carotene supplementation in smokers reduces the frequency of micronuclei in sputum. Br J Cancer. 1992;66:1164–8. [PMC free article: PMC1978057] [PubMed: 1457358]

van Poppel G , Poulsen H , Loft S , Verhagen H . No influence of β-carotene on oxidative DNA damage in male smokers. J Natl Cancer Inst. 1995;87:310–1. [PubMed: 7707423]

McLarty JW , Holiday DB , Girard WM . et al. β-Carotene, vitamin A, and lung cancer chemoprevention: results of an intermediate endpoint study. Am J Clin Nutr. 1995;62(6 Suppl):1431S–8S. [PubMed: 7495244]

Kurie JM , Lotan R , Lee JJ . et al. Randomized, placebo-controlled trial of 9-cis retinoic acid (9cRA) versus 13-cis retinoic acid (13cRA) plus alpha-tocopherol (AT) in the reversal of biomarkers of bronchial preneoplasia in former smokers. Proc Amer Soc Clinical Oncol. 2002;21:295a.

Lam S , MacAulay C , le Riche JC . et al. A randomized phase IIb trial of anethole dithiolethione in smokers with bronchial dysplasia. J Natl Cancer Inst. 2002;94:1001–9. [PubMed: 12096085]

The Alpha-Tocopherol, Beta-Carotene Cancer Prevention Study Group. The effect of vitamin E and beta-carotene on the incidence of lung cancer and other cancers in male smokers. N Engl J Med. 1994;330:1029–35. [PubMed: 8127329]

Wang X-D , Liu C , Bronson RT . et al. Retinoid signaling and activator protein-1 expression in ferrets given β-carotene supplements and exposed to tobacco smoke. J Natl Cancer Inst. 1999;91:60–6. [PubMed: 9890171]

Paolini M , Cantelli-Forti G , Perocco P . et al. Co-carcinogenic effect of β-carotene. Nature. 1999;398:760–1. [PubMed: 10235258]

Heinonen OP , Albanes D , Virtamo J . et al. Prostate cancer and supplementation with α-tocopherol and beta-carotene: incidence and mortality in a controlled trial. J Natl Cancer Inst. 1998;90:440–6. [PubMed: 9521168]

Omenn GS , Goodman GE , Thornquist MD . et al. Effects of a combination of beta carotene and vitamin A on lung cancer and cardiovascular disease. N Engl J Med. 1996;334:1150–5. [PubMed: 8602180]

Pastorino U , Infante M , Maioli M . et al. Adjuvant treatment of stage I lung cancer with high-dose vitamin A. J Clin Oncol. 1993;11:1216–22. [PubMed: 8391063]

van Zandwijk N , Dalesio O , Pastorino U . et al. EUROSCAN, a randomized trial of vitamin A and N-acetylcysteine in patients with head and neck cancer or lung cancer. For the European Organization for Research and Treatment of Cancer Head and Neck and Lung Cancer Cooperaive Groups. J Natl Cancer Inst. 2000;92:977–86. [PubMed: 10861309]

Lippman SM , Lee JJ , Karp DD . et al. Randomized phase III intergroup trial of isotretinoin to prevent second primary tumors in stage I non-small-cell lung cancer. J Natl Cancer Inst. 2001;93:605–18. [PubMed: 11309437]

Giardiello FM , Hamilton SR , Krush AJ . et al. Treatment of colonic and rectal adenomas with sulindac in familial adenomatous polyposis. N Engl J Med. 1993;328:1313–6. [PubMed: 8385741]

Steinbach G , Lynch PM , Phillips RK . et al. The effect of celecoxib, a cyclooxygenase-2 inhibitor, in familial adenomatous polyposis. N Engl J Med. 2000;342:1946–52. [PubMed: 10874062]

Phillips RK , Wallace MH , Lynch PM . et al. A randomised, double blind, placebo controlled study of celecoxib, a selective cyclooxygenase 2 inhibitor, on duodenal polyposis in familial adenomatous polyposis. Gut. 2002;50:857–60. [PMC free article: PMC1773237] [PubMed: 12010890]

Giardiello FM , Yang VW , Hylind LM . et al. Primary chemoprevention of familial adenomatous polyposis with sulindac. N Engl J Med. 2002;346:1054–9. [PMC free article: PMC2225537] [PubMed: 11932472]

Baron JA , Cole BF , Mott LA . Aspirin chemoprevention of colorectal adenomas. Proc Am Assoc Cancer Res. 2002;43:669.

Baron JA , Tosteson TD , Wargovich MJ . et al. Calcium supplementation and rectal mucosal proliferation: a randomized controlled trial. J Natl Cancer Inst. 1995;87:1303–7. [PubMed: 7658482]

Wallace K , Baron JA , Cole BF . et al. Calcium carbonate chemoprevention in the large bowel: effects on hyperplastic polyps, tubular adenomas, and more advanced lesions. Proc Am Assoc Cancer Res. 2002;43:163–4.

Schatzkin A , Lanza E , Corle D . et al. Lack of effect of a low-fat, high-fiber diet on the recurrence of colorectal adenomas. N Engl J Med. 2000;342:1149–55. [PubMed: 10770979]

Alberts DS , Martinez ME , Roe DJ . et al. Lack of effect of a high-fiber cereal supplement on the recurrence of colorectal adenomas. N Engl J Med. 2000;342:1156–62. [PubMed: 10770980]

Levin B . Dietary intake and recurrence of colorectal adenoma. Lancet. 2000;356:1286–7. [PubMed: 11073010]

Hwang DH , Fung V , Dannenberg AJ . National Cancer Institute workshop on chemopreventive properties of nonsteroidal anti-inflammatory drugs: role of COX-dependent and independent mechanisms. Neoplasia. 2002;4:1–7. [PMC free article: PMC1550326] [PubMed: 11896563]

Labayle D , Fischer D , Vielh P . et al. Sulindac causes regression of rectal polyps in familial adenomatous polyposis. Gastroenterology. 1991;101:635–9. [PubMed: 1650315]

Wargovich MJ , Isbell G , Shabot M . et al. Calcium supplementation decreases rectal epithelial cell proliferation in subjects with sporadic adenoma. Gastroenterology. 1992;103:92–7. [PubMed: 1612362]

Stern HS , Gregorie RC , Koshtan H . Long-term effects of dietary calcium on risk markers for colon cancer in patients with familial polyposis. Surgery. 1990;108:528–33. [PubMed: 2168586]

Gregoire RC , Stern HS , Yeung KS . et al. Effect of calcium supplementation on mucosal cell proliferation in high risk patients for colon cancer. Gut. 1989;30:376–82. [PMC free article: PMC1378462] [PubMed: 2707638]

Barsoum GH , Hendrickse C , Winslet MC . et al. Reduction of mucosal crypt cell proliferation in patients with colorectal adenomatous polyps by dietary calcium supplementation. Br J Surg. 1992;79:581–3. [PubMed: 1611460]

Bostick RM , Potter JD , Fosdick L . et al. Calcium and colorectal epithelial cell proliferation: a preliminary randomized, double-blinded, placebo-controlled clinical trial. J Natl Cancer Inst. 1993;85:132–41. [PubMed: 8418302]

Cats A , Kleibeuker JH , van der Meer R . et al. Randomized, double-blind, placebo-controlled intervention study with supplemental calcium in families with hereditary nonpolyposis colorectal cancer. J Natl Cancer Inst. 1995;87:598–603. [PubMed: 7752258]

Baron JA , Beach M , Mandel JS . et al. Calcium supplements for the prevention of colorectal adenomas. N Engl J Med. 1999;340:101–7. [PubMed: 9887161]

Kikendall JW , Mobarhan S , Nelson R . et al. Oral beta carotene does not reduce the recurrence of colorectal adenomas [abstract] Am J Gastroenterol. 1991;36:1356.

Bussey HJR , DeCosse JJ , Deschner EE . et al. A randomized trial of ascorbic acid in polyposis coli. Cancer. 1982;50:1434–9. [PubMed: 7049351]

McKeown-Eyssen G , Holloway C , Jazmaji V . et al. A randomized trial of vitamins C and E in the prevention of recurrence of colorectal polyps. Cancer Res. 1988;48:4701–5. [PubMed: 3293777]

DeCosse JJ , Miller HH , Lesser ML . Effect of wheat fiber and vitamins C and E on rectal polyps in patients with familial adenomatous polyposis. J Natl Cancer Inst. 1989;81:1290–7. [PubMed: 2549261]

MacLennan R , Macrae F , Bain C . et al. Randomized trial of intake of fat, fiber, and beta carotene to prevent colorectal adenomas. J Natl Cancer Inst. 1995;87:1760–6. [PubMed: 7473832]

Alberts D , Rees-McGee S , Einspahr J . et al. Double-blind, placebo controlled study of wheat bran fiber (WBF) vs. calcium carbonate (CALC) in patients with resected adenomatous polyps. Proc Am Assoc Cancer Res. 1992;33:207.

Paganelli GM , Biasco G , Brandi G . et al. Effect of vitamins A, C, and E supplementation on rectal cell proliferation in patients with colorectal adenomas. J Natl Cancer Inst. 1992;84:47–51. [PubMed: 1738173]

Roncucci L , Donato PD , Carati L . et al. Antioxidant vitamins or lactulose for the prevention of the recurrence of colorectal adenomas. Dis Colon Rectum. 1993;36:227–34. [PubMed: 8449125]

Greenberg ER , Baron JA , Tosteson TD . et al. A clinical trial of antioxidant vitamins to prevent colorectal adenoma. N Engl J Med. 1994;331:141–7. [PubMed: 8008027]

Kligman AM, Thorne EG. Topical therapy of actinic keratosis with tretinoin. In: Marks, R, editor. Retinoids in cutaneous malignancy. Cambridge (MA): Blackwell Scientific Publications; 1991. p. 66–73.

Moriarity M , Dunn J , Darragh A . et al. Etretinate in treatment of actinic keratosis: a double blind crossover study. Lancet. 1982;1:364–5. [PubMed: 6120350]

Watson AB . Preventative effect of etretinate therapy on multiple actinic keratoses. Cancer Detect Prev. 1986;9:161–5. [PubMed: 3524840]

Kraemer KH , DiGiovanna JJ , Moshell AN . et al. Prevention of skin cancer in xeroderma pigmentosum with the use of oral isotretinoin. N Engl J Med. 1988;318:1633–7. [PubMed: 3287161]

Bouwes Bavinck JN , Tiben LM , Van Der Woude FJ . et al. Prevention of skin cancer and reduction of keratotic skin lesions during acitretin therapy in renal transplant recipients: a double-blind, placebo-controlled study. J Clin Oncol. 1995;13:1933–8. [PubMed: 7636533]

Greenberg ER , Baron JA , Stukel TA . et al. A clinical trial of β-carotene to prevent basal-cell and squamous-cell cancers of the skin. N Engl J Med. 1990;323:789–95. [PubMed: 2202901]

Tangrea JA , Edwards BK , Taylor PR . et al. Long-term therapy with low-dose isotretinoin for prevention of basal cell carcinoma: a multicenter clinical trial. J Natl Cancer Inst. 1992;84:328–32. [PubMed: 1738183]

Moon TE , Levine N , Cartmel B . et al. Effect of retinol in preventing squamous cell skin cancer in moderate-risk subjects: a randomized, double-blind, controlled trial. Cancer Epidemiol Biomarkers Prev. 1997;6:949–56. [PubMed: 9367069]

Levine N , Moon TE , Cartmel B . et al. Trial of retinol and isotretinoin in skin cancer prevention: a randomized, double-blind, controlled trial. Southwest Skin Cancer Prevention Study Group. Cancer Epidemiol Biomarkers Prev. 1997;6:957–61. [PubMed: 9367070]

Clark LC , Combs GF Jr, Turnbull BW . et al. Effects of selenium supplementation for cancer prevention in patients with carcinoma of the skin. JAMA. 1996;276:1957–63. [PubMed: 8971064]

Yarosh D , Klein J , O'Connor A . et al. Effect of topically applied T4 endonuclease V in liposomes on skin cancer in xeroderma pigmentosum: a randomised study. Lancet. 2001;357:926–9. [PubMed: 11289350]

Fisher B , Costantino JP , Wickerham DL . et al. Tamoxifen for prevention of breast cancer: report of the national surgical adjuvant breast and bowel project P-1 study. J Natl Cancer Inst. 1998;90:1371–88. [PubMed: 9747868]

Lippman SM , Brown PH . Tamoxifen prevention of breast cancer: an instance of the fingerpost. J Natl Cancer Inst. 1999;91:1809–19. [PubMed: 10547388]

Fisher B , Dignam J , Wolmark N . et al. Tamoxifen in treatment of intraductal breast cancer: national surgical adjuvant breast and bowel project B-24 randomised controlled trial. Lancet. 1999;353:1993–2000. [PubMed: 10376613]

Cummings SR , Eckert S , Krueger KA . et al. The effect of raloxifene on risk of breast cancer in postmenopausal women: results from the MORE randomized trial. JAMA. 1999;281:2189–97. [PubMed: 10376571]

Veronesi U , Maisonneuve P , Costa A . et al. Prevention of breast cancer with tamoxifen: preliminary findings from the Italian randomised trial among hysterectomised women. Lancet. 1998;352:93–7. [PubMed: 9672273]

Powles T , Eeles R , Ashley S . et al. Interim analysis of the incidence of breast cancer in the Royal Marsden Hospital tamoxifen randomised chemoprevention trial. Lancet. 1998;352:98–101. [PubMed: 9672274]

Veronesi U , De Palo G , Marubini E . et al. Randomized trial of fenretinide to prevent second breast malignancy in women with early breast cancer. J Natl Cancer Inst. 1999;91:1847–56. [PubMed: 10547391]

Munoz N , Bang LJ , Day NE . et al. No effect of riboflavin, retinol, and zinc on prevalence of precancerous lesions of oesophagus: randomized double-blind intervention study in high-risk population of China. Lancet. 1985;2:111–4. [PubMed: 2862315]

Munoz N , Hayashi M , Bang LJ . et al. Effect of riboflavin, retinol and zinc on micronuclei of buccal mucosa and of the esophagus: a randomized double-blind intervention study in China. J Natl Cancer Inst. 1987;79:687–91. [PubMed: 3477659]

Wahrendorf J , Munoz N , Jian-Bang L . et al. Blood, retinol and zinc riboflavin status in relation to precancerous lesions of the esophagus: findings from a vitamin intervention trial in the People's Republic of China. Cancer Res. 1988;48:2280–3. [PubMed: 3280125]

Zaridze D , Evstifeeva T , Boyle P . Chemoprevention of oral leukoplakia and chronic esophagitis in an area of high incidence of oral and esophageal cancer. Ann Epidemiol. 1993;3:225–34. [PubMed: 8275193]

Blot WJ , Li JY , Taylor PR . et al. Linxian nutrition intervention trials: supplementation with specific vitamin/mineral combinations, cancer incidence, and disease-specific mortality in the general population. J Natl Cancer Inst. 1993;85:1483–92. [PubMed: 8360931]

Li J-Y , Taylor PR , Li B . et al. Linxian nutrition intervention trials: multiple vitamin/mineral supplementation, cancer incidence, and disease-specific mortality among adults with esophageal dysplasia. J Natl Cancer Inst. 1993;85:1492–8. [PubMed: 8360932]

Buiatti E , Munoz N , Vivas J , Cano E . et al. Difficulty in eradicating Helicobacter pylori in a population at high risk for stomach cancer in Venezuela. Cancer Causes Control. 1994;5:249–54. [PubMed: 8061173]

Sporn MB , Squire RA , Brown CC . et al. 13-cis-retinoic acid inhibition of bladder carcinogenesis in the rat. Science. 1977;195:487–9. [PubMed: 835006]

Alfthan O , Tarkkanen J , Grohn P . et al. Tigason (etretinate) in prevention of recurrence of superficial bladder tumors. Eur Urol. 1983;9:6–9. [PubMed: 6337054]

Pederson H , Wolf H , Jensen SK . et al. Administration of a retinoid as prophylaxis of recurrent noninvasive bladder tumors. Scand J Urol Nephrol. 1994;18:121–3. [PubMed: 6379859]

Studer UE , Biedermann C , Chollet D . et al. Prevention of recurrent superficial bladder tumors by oral etretinate: preliminary results of a randomized, double-blind, multicenter trial in Switzerland. J Urol. 1984;131:47–9. [PubMed: 6361284]

Lamm DL , Riggs DR , Shrivers JS . et al. Megadose vitamins in bladder cancer: a double-blind clinical trial. J Urol. 1994;151:21–6. [PubMed: 8254816]

Decensi A , Bruno S , Costantini M . et al. Phase IIa study of fenretinide in superficial bladder cancer, using DNA flow cytometry as an intermediate end point. J Natl Cancer Inst. 1994;86:138–41. [PubMed: 8271297]

Byrne MA , Moller BR , Taylor-Robinson D . et al. The effect of interferon on human papillomaviruses associated with cervical intraepithelial neoplasia. Br J Obstet Gynaecol. 1986;93:1136–44. [PubMed: 3022785]

Yliskoski M , Cantell K , Syrjanen K . et al. Topical treatment with human leukocyte interferon of HPV 16 infections associated with cervical and vaginal intraepithelial neoplasias. Gynecol Oncol. 1990;36:353–7. [PubMed: 2156764]

Frost L , Skajaa K , Hvidman LE . et al. No effect of intralesional injection of interferon on moderate cervical intraepithelial neoplasia. Br J Obstet Gynaecol. 1990;97:626–30. [PubMed: 2167727]

Dunham AM , McCartney JC , McCance DJ . et al. Effect of perilesional injection of alpha-interferon on cervical intraepithelial neoplasia and associated human papillomavirus infection. J R Soc Med. 1990;83:490–2. [PMC free article: PMC1292772] [PubMed: 2172535]

Butterworth CE , Hatch KD , Soong S-J . et al. Oral folic acid supplementation for cervical dysplasia: a clinical intervention trial. Am J Obstet Gynecol. 1992;166:803–9. [PubMed: 1312773]

Childers JM , Chu J , Voigt LF . et al. Chemoprevention of cervical cancer with folic acid: a phase III Southwest Oncology Group intergroup study. Cancer Epidemiol Biomarkers Prev. 1995;4:155–9. [PubMed: 7742723]

De Vet HCW , Knipschild PG , Willebrand D . et al. The effect of beta-carotene on the regression and progression of cervical dysplasia: a clinical experiment. J Clin Epidemiol. 1991;44:273–83. [PubMed: 1999687]

Meyskens FL , Surwit E , Moon TE . et al. Enhancement of regression of cervical intraepithelial neoplasia II (moderate dysplasia) with topically applied all-trans-retinoic acid: a randomized trial. J Natl Cancer Inst. 1994;86:539–43. [PubMed: 8133537]

Follen M , Atkinson EN , Schottenfeld D . et al. A randomized clinical trial of 4-hydroxyphenylretinamide for high-grade squamous intraepithelial lesions of the cervix. Clin Cancer Res. 2001;7:3356–65. [PubMed: 11705848]

Keefe KA , Schell MJ , Brewer C . et al. A randomized, double blind, phase III trial using oral beta-carotene supplementation for women with high-grade cervical intraepithelial neoplasia. Cancer Epidemiol Biomarkers Prev. 2001;10:1029–35. [PubMed: 11588128]

Hennekens CH , Burning JE , Manson JE . et al. Lack of effect of long-term supplementation with beta carotene on the incidence of malignant neoplasms and cardiovascular disease. N Engl J Med. 1996;334:1145–9. [PubMed: 8602179]

Lee I-M , Cook NR , Manson JE . et al. Beta carotene supplementation and incidence of cancer and cardiovascular disease: the Women's Health Study. J Natl Cancer Inst. 1999;91:2102–6. [PubMed: 10601381]